• 25-Hydroxycholesterol, AMPK Activation, and Macrophage Immun

  2026-05-29

  Xiao et al. (2024) uncover a lysosome-centered mechanism in which 25-hydroxycholesterol (25HC) drives AMPKα activation to reprogram tumor-associated macrophages (TAMs) toward an immunosuppressive phenotype. Their findings clarify cholesterol metabolism's role in immune evasion and identify CH25H as a potential therapeutic checkpoint to enhance anti-tumor responses.

• L-Ornithine in Urea Cycle Research: Protocols & Innovations

  2026-05-29

  L-Ornithine (B8919) from APExBIO offers high-purity, reproducible solubility, and has become pivotal for dissecting the hepatic–neural axis in metabolic and neurotoxicology research. This guide delivers evidence-based workflows, protocol optimizations, and troubleshooting strategies to help researchers unlock the full potential of (S)-2,5-diaminopentanoic acid in both classic and emerging assay formats.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-05-28

  A recent study introduces a nanoparticle system for systemic delivery of PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. This approach directly restores tumor suppressor function and inhibits the PI3K/Akt pathway, offering a promising strategy for resistant cancer models.

• Ciprofloxacin in Research: Advanced Protocols and Use-Cases

  2026-05-28

  Ciprofloxacin, a high-purity fluoroquinolone antibiotic from APExBIO, is redefining experimental workflows in bacterial infection models and antimicrobial resistance research. Explore protocol enhancements, troubleshooting tactics, and practical insights translating recent nanomedicine breakthroughs into lab-ready applications.

• SR 11302: Advanced AP-1 Transcription Factor Inhibitor Workf

  2026-05-27

  SR 11302 stands out as a highly selective AP-1 transcription factor inhibitor, enabling precise inhibition of tumor promotion pathways in cancer models. This guide delivers actionable protocols, troubleshooting insights, and translates new immunomodulatory findings into practical, reproducible cancer research workflows.

• a-MSH, amide: Advanced Workflows for Pigmentation Regulation

  2026-05-27

  a-MSH, amide from APExBIO enables precise, reproducible modulation of melanin synthesis and inflammation in cell-based assays, supporting both basic and translational research. This article delivers optimized experimental protocols, troubleshooting guidance, and practical insights for maximizing the impact of alpha-melanocyte-stimulating hormone amide in pigmentation and anti-inflammatory studies.

• Innovating Cell Proliferation Assays: EdU Imaging Kits (HF59

  2026-05-26

  EdU Imaging Kits (HF594) enable robust, fluorescence-based quantification of cell proliferation by measuring DNA synthesis with superior sensitivity. Discover how this technology advances translational oncology research and offers unique insights beyond conventional assays.

• Vancomycin as a Precision Modulator of Gut-Immune Interactio

  2026-05-26

  Explore how Vancomycin, a glycopeptide antibiotic, enables deep investigation of bacterial cell wall synthesis and immune-microbiome dynamics. This article uniquely bridges molecular mechanism, emerging research insights, and advanced assay design for MRSA and Clostridium difficile infection studies.

• Hematoxylin and Eosin Staining Kit: Technical Usage Guide

  2026-05-25

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides ready-to-use solutions for precise tissue morphology visualization in research settings. It solves the problem of workflow variability in histopathological and cytological staining for paraffin-embedded and frozen tissue sections. This kit is strictly for scientific research use and should not be applied in diagnostic or clinical contexts.

• Amyloid Beta-Peptide (1-40) (human): New Insights in Microgl

  2026-05-25

  Explore the evolving role of Amyloid Beta-Peptide (1-40) (human) in Alzheimer’s disease research, focusing on its impact on microglial regulation and neuroinflammation. This article offers a unique synthesis of recent mechanistic breakthroughs, practical assay implications, and advanced applications using APExBIO’s rigorously characterized peptide.

• Dovitinib (TKI-258): Optimizing RTK Inhibition in Cancer Res

  2026-05-24

  Dovitinib (TKI-258) stands out as a multitargeted RTK inhibitor, enabling precise modulation of oncogenic signaling and apoptosis induction in diverse cancer models. This guide delivers workflow enhancements, troubleshooting insights, and protocol parameters for advanced applications, with direct connections to chamber-specific stem cell differentiation and translational oncology.

• CLK2 Targeting to Overcome Platinum Resistance in Ovarian Ca

  2026-05-23

  This study identifies Cdc2-like kinase 2 (CLK2) as a key driver of platinum resistance in ovarian cancer by enhancing BRCA1-dependent DNA repair. Targeting CLK2 could improve therapeutic response, providing a mechanistically informed strategy to address one of the most critical challenges in gynecologic oncology.

• High-Throughput BBB Permeability Modeling with Lysosomal Tra

  2026-05-22

  This study introduces a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, capable of accurately predicting CNS drug permeability by integrating lysosomal trapping correction. The approach streamlines early-stage screening, enabling more reliable selection of brain-penetrant compounds and minimizing reliance on resource-intensive in vivo studies.

• Clozapine and Precision Neuromodulation: New Horizons in Sch

  2026-05-22

  Explore how Clozapine, a leading atypical antipsychotic medication, intersects with advanced neuromodulation strategies to unravel schizophrenia mechanisms. This article uniquely connects receptor pharmacology, ERK1/2 signaling, and innovations in magnetic stimulation for translational research.

• Ciprofloxacin in Research: Protocols, Innovations & Troubles

  2026-05-21

  Ciprofloxacin’s unique dual role as a fluoroquinolone antibiotic and a sonosensitizer is unlocking new horizons for antimicrobial resistance and cancer theranostics studies. This article distills actionable workflows, protocol optimizations, and troubleshooting strategies to maximize reproducibility and experimental impact using high-purity Ciprofloxacin from APExBIO.

15511 records 1/1035 page Next 12345 下5页 Last page